Lung Cancer, An Issue of Hematology/Oncology Clinics
This issue of Hematology/Oncology Clinics will focus on lung cancer; specifically, Genomics in lung cancer; Neoadjuvant and adjuvant therapy for NSCLC; Treatment of locally advanced NSCLC; First line systemic therapy for NSCLC; Second line chemotherapy and beyond for NSCLC; Treatment of EGFR mutant tumors; Treatment of ALK positive tumors; New targets in NSCLC; Immunotherapy; Advances in Small cell lung cancer; and many more!
|Author Information||By Roy S. Herbst, MD, PhD, Ensign Professor of Medicine, Professor of Pharmacology, Chief of Medical Oncology, Associate Director for Translational Research, Yale Comprehensive Cancer Center, Yale School of Medicine and Daniel Morgensztern, MD, Washington University School of Medicine|
|Stock Status||In Stock|
Write Your Own Review